Axonal transport deficit in a KIF5A–/– mouse model by Karle, Kathrin N. et al.
ORIGINAL ARTICLE
Axonal transport deficit in a KIF5A
–/– mouse model
Kathrin N. Karle & Diana Möckel & Evan Reid &
Ludger Schöls
Received: 6 February 2012 /Accepted: 13 March 2012 /Published online: 1 April 2012
# The Author(s) 2012. This article is published with open access at Springerlink.com
Abstract Hereditary spastic paraplegia (HSP) is a neurode-
generative disorder preferentially affecting the longest cor-
ticospinal axons. More than 40 HSP genetic loci have been
identified, among them SPG10, an autosomal dominant
HSP caused by point mutations in the neuronal kinesin
heavy chain protein KIF5A. Constitutive KIF5A knockout
(KIF5A
–/–) mice die early after birth. In these mice, lungs
were unexpanded, and cell bodies of lower motor neurons in
the spinal cord swollen, but the pathomechanism remained
unclear. To gain insights into the pathophysiology, we char-
acterized survival, outgrowth, and function in primary motor
and sensory neuron cultures from KIF5A
–/– mice. Absence of
KIF5A reduced survival in motor neurons, but not in sensory
neurons. Outgrowth of axons and dendrites was remarkably
diminishedinKIF5A
–/– motor neurons.The number ofaxonal
branches was reduced, whereas the number of dendrites was
not altered. In KIF5A
–/– sensory neurons, neurite outgrowth
was decreased but the number of neurites remained un-
changed. In motor neurons maximum and average velocity
of mitochondrial transport was reduced both in anterograde
and retrogradedirection.Our resultspoint out a roleofKIF5A
in process outgrowth and axonal transport of mitochondria,
affecting motor neurons more severely than sensory neurons.
This gives pathophysiological insights into KIF5A associated
HSP, and matches the clinical findings of predominant degen-
eration of the longest axons of the corticospinal tract.
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Introduction
The hereditary spastic paraplegias (HSPs) comprise a grow-
ing number of clinically and genetically heterogeneous dis-
eases. Their common feature is axonal degeneration of the
corticospinal tract in a length-dependent manner, so that the
longest axons innervating lower motor neurons that supply
the leg muscles are affected, whereas the shorter fibers that
innervate lower motor neurons supplying the arms are
mainly spared. Clinically, this leads to progressive gait
disturbance due to lower limb spasticity [1–3]. More than
40 HSP loci and 20 HSP genes are registered in the
HUGO Gene Nomenclature Committee database [4].
Autosomal dominant, autosomal recessive, and X-linked
modes of inheritance occur in HSP [5]. Increasing knowledge
about physiological functions of genes mutated in HSP has
highlighted a few common pathogenic mechanisms,
such as myelin sheath formation, mitochondrial func-
tion, and membrane trafficking and transport [6–8].
Axons rely on many of these functions in a length-
dependent manner, offering an explanation why motor
neurons to the legs with an axon length up to 1 m are
especially sensitive to dysfunction.
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DOI 10.1007/s10048-012-0324-ySPG10 is an autosomal dominantly inherited subtype of
HSP that is caused by mutations in the neuronal motor
protein kinesin heavy chain (KHC) KIF5A. SPG10 accounts
for 3 to 5 % of autosomal dominant HSPs in European
families [9, 10]. As in most HSP subtypes, disease onset
varies from early childhood to adulthood, and the disease
may cause pure spastic paraplegia, or alternatively forms
complicated by cognitive dysfunction, peripheral neuropa-
thy, parkinsonism, and/or epilepsy. Nearly all mutations
causing SPG10 are heterozygous missense mutations in
the motor domain of KIF5A [9–14].
The kinesin superfamily provides motors for ATP-
dependent transport along microtubules, generally in the
plus end direction (which in axons is the anterograde direc-
tion). Kinesin-1, formerly called conventional kinesin, acts
as a motor for fast axonal transport of membranous organ-
elles (50–200 mm per day) as well as for slow axonal
transport of cytoplasmic proteins (0.1–3 mm per day)
[15–17]. Kinesin-1 is a heterotetramer consisting of two
kinesin heavy chains (KIF5A, KIF5B, or KIF5C), and two
kinesin light chains [18]. Kinesin heavy chains as well as
kinesin light chains only homodimerize, whereas there is no
specificity in the interaction between heavy and light chains
[19]. The heavy chains contain the motor domain, cargo
specificity is thought to be mediated mainly via kinesin light
chains and/or additional linker proteins, e.g., milton and
miro are likely to act as linker proteins binding mitochondria
to kinesin heavy chain protein [20]. Other cargoes trans-
ported by kinesin-1 include lysosomes [21], membrane-
associated SNARE proteins [22], syntaxin-1-containing
vesicles [23], tubulin [24], apolipoprotein E receptor 2
[25], and phosphorylated amyloid precursor protein (APP)
[26]. Circumstantial evidence that KIF5A is involved in
mitochondrial transport comes from primary extraembryon-
ic membrane cells lacking the KIF5B gene. The abnormal
perinuclear clustering of mitochondria in these cells can be
rescued by overexpression of the KIF5A gene [27]. In vitro
experiments with KIF5A proteins carrying human SPG10
missense mutations of the motor domain revealed reduced
transport velocity and reduced binding on microtubules
respectively [28].
KIF5A knockout (KO) mice die shortly after birth. The
amount of KIF5B and KIF5C was not significantly changed.
Histologically, lungs were not well expanded, and cell bod-
ies of lower motor neurons in the spinal cord swollen
whereas the brain did not seem to be affected. To overcome
perinatal lethality conditional knockout mice were generated
with neuronal knockout of KIF5A induced by synapsin-
promoted Cre-recombinase transgene. These mice showed
seizures, hind limb paralysis, and sensory neuron degener-
ation in later stages. Histological analysis of cell bodies
from sensory neurons revealed an accumulation of neuro-
filament (L, M, H), in Western Blots of DRGs the amount of
neurofilament protein was increased, whereas the amount of
markers for fast axonal transport (APP, Rab3, synaptophy-
sin) was not changed [29]. In superior cervical ganglia
neurons, frequency and velocity of neurofilament move-
ments were reduced both in anterograde and retrograde
direction [30]. In a mouse model with the human N256S
mutation in the KIF5A gene cortical neurons revealed an
increased retrograde velocity of neurofilament M transport,
whereas anterograde velocity was not affected. The frequen-
cy of anterograde and retrograde movements was decreased
[31]. But probably neurofilament is not the only important
cargo transported by KIF5A.
In this work, we established primary cell cultures of
motor and sensory neurons of constitutive KIF5A KO mice
and characterized vitality, morphology, and function. By
live cell imaging, we revealed an axonal transport defect
of mitochondria. These results can improve insights into
mechanisms underlying the length-dependent axonal degen-
eration and selective damage of motor neurons in SPG10.
Materials and methods
Histology of mouse brain, spinal cord, and muscle
KIF5A
+/– mice were obtained from Mutant Mouse Regional
Resource Centers, University of California, Davis, USA.
Wildtype C57Bl/6N mice were purchased from Charles
River Laboratories (Sulzfeld, Germany). For histological
analysis embryos were dissected from pregnant mice at
embryonic day (E) 18.5. Brain, spinal cord, and proximal
leg muscle were isolated and fixed in 4 % paraformaldehyde
for 24 hours. After dehydration tissues were embedded in
paraffin. 5 μm sections of brain and spinal cord were stained
with cresyl violet (MEDITE® GmbH, Burgdorf, Germany)
whereas 5 μm muscle sections were treated with hematoxylin
eosin (MEDITE® GmbH). Images were acquired with a CCD
camera (Axio Imager Z1, AxioCam MRc, Carl Zeiss Micro-
Imaging GmbH, Jena, Germany).
For morphological assessment of spinal motor neurons
the size of cell bodies and nuclei were analyzed in at least 36
cells from three independent experiments. Statistical evalu-
ation was performed by ANOVA followed by Bonferroni
correction (SPSS 17.0, SPSS Inc., Chicago, USA).
Mouse embryonic motor and sensory neuron culture
Embryos were isolated from pregnant mice at E 12.5. The
lumbar spinal cord and the laterally adjacent DRGs were
dissected and transferred to HBSS (invitrogen™,C a r l s b a d ,
USA) and 1× PBS (invitrogen™)r e s p e c t i v e l y .T h et r y p s i n
reaction (0.05 %, Biochrom AG, Berlin, Germany) was
stopped in spinal cord tissue after 15 min with 0.01 % trypsin
170 Neurogenetics (2012) 13:169–179inhibitor (Sigma-Aldrich Co., St. Louis, MO, USA), and in
DRGs after 35 min with HAMS F14 Powder Medium (invi-
trogen™), enriched with 10 % heat-inactivated horse serum
(Linaris Biologische Produkte GmbH, Wertheim-Bettingen,
Germany) and 35 mM KCl. Tissues were triturated.
Motor neurons of the spinal cord were isolated via Lectin
antibody (20 μg/ml, Sigma-Aldrich) that has been attached
to 24 well CELLSTAR® plates (Greiner Bio-One GmbH,
Frickenhausen, Germany). After panning for 30 min, the
supernatant was removed, and adherent motor neurons
washed three times with Neurobasal medium (invitro-
gen™). Afterwards motor neurons were resolved with
30 mM KCl and 137 mM NaCl (in aqua dest.). After
centrifugation (400 g, 5 min, Multifuge3 S-R, Heraeus Hold-
ing GmbH, Hanau, Germany), and removal of the superna-
tant, motor neurons were resuspended in Neurobasal medium
with 10 % heat-inactivated horse serum, 2 % B27 supplement
(invitrogen™) and 500 μM GlutaMAX-I-Supplement (invi-
trogen™). CNTF (upstate®, Millipore™,B i l l e r i c a ,U S A )a n d
BDNF (CHEMICON®, Millipore™) were added in a final
concentration of 1 ng/ml. Cells were plated on six-well cell
culture CELLSTAR® plates (Greiner Bio-One GmbH) with
glass coverslips (22 mm diameter, Carl Roth GmbH + Co.
KG, Karlsruhe, Germany) and on Lab-Tek™ 8 Chamber
Slide™ system (Nalge Nunc International, Rochester, USA)
precoated with 1× poly-D-lysine (Sigma-Aldrich) and natural
mouse laminin (Sigma-Aldrich, 2,5 μg/ml) at a density of
2,000 cells/cm
2. Cells were incubated at 37°C and 5 % CO2.
Fifty percent of the medium was replaced every day.
To suppress growth of non-neuronal cells, sensory neurons
were pre-plated after trituration on 24-well plates in HAMS
F14 Powder Medium with 10 % heat-inactivated horse serum
and 35 mM KCl. After 2 h the supernatant was transferred to
six-well plates precoated with poly-L-ornithine and laminin.
BDNF, GDNF (Alomone Labs Ltd., Jerusalem, Israel), NGF
2.5S (Alomone Labs Ltd.), and NT-3 (Alomone Labs Ltd.)
were added in a final concentration of 1 ng/ml. Cells were
incubated at 37°C and 5 % CO2.
Genotyping of KIF5A KO mice
Genomic DNA from mouse tissues was isolated by standard
methods. The following primers were used to detect the KIF5A
gene: KIF5AI_P1 5′ GAT ACT CCA AGG CTG GGA ACA
TA 3′, KIF5AI_P2 5′ TGT GGA GGT CAG AGG TCA AGT
3′, loxP5AI_P3 5′ CGG TAC CCG GGG ATC AAT TCG AG
3′ (metabion international AG, Martinsried, Germany). PCR
mix includes 1 μl of DNA (concentration 100–200 ng/μl), 2 μl
10× buffer, 0.4 μld N T P s( 1 0m M ) ,0 . 1μl SAWADY hot taq-
DNA-polymerase (5 U/μl, PEQLAB Biotechnologie GmbH,
Erlangen, Germany), 4 μl Enhancer (PEQLAB Biotechnologie
GmbH), 0.2 μl KIF5AI_P1 (10 pmol/μl), 0.1 μl KIF5A_P2
(10 pmol/μl), 0.1 μl loxP5AI_P3 (10 pmol/μl), water dest.
added to 20 μl. PCR conditions (Bio-Rad Dyad Thermal
Cycler, Bio-Rad Laboratories Inc., Hercules, USA) were acti-
vation of taq-DNA-polymerase at 95°C for 15 min, followed
by 35 cycles with denaturation at 94°C for 45 s, annealing at
60°C for 45 s, elongation at 72°C for 1 min, and a last
elongation at 72°C for 10 min PCR products are a wildtype
band (P1/P2) at ∼450 bp and a mutated band (P1/P3) at
∼300 bp.
Determination of motor and sensory neuron survival
The first counting was done 4 h after plating the cells, when
they were attached to the bottom. Then, every day the number
of surviving cells in ten fields of view (1.16 mm
2) was counted
under a phase-contrast microscope (Olympus Deutschland
GmbH, Hamburg, Germany). The number of initially counted
cells was set 100 % (day 0). The percentage of surviving cells
was calculatedforeverydayinculture. The results from atleast
four independent experiments were pooled. So for each geno-
type at least 11 individuals were counted, and are given as
mean and standard error of mean. Statistical significance of
differences was assessed by ANOVA followed by Bonferroni
correction (SPSS Statistics 17.0, SPSS Inc.).
Immunocytochemistry of motor and sensory neurons
After a definite number of days in culture motor and sensory
neurons on glass coverslips were fixed with 4 % parafor-
maldehyde (Carl Roth GmbH + Co. KG) for 30 min and
washed three times with 1× PBS. After treatment with 0.1 %
Igepal CA-630 (Sigma-Aldrich) for 30 min unspecific bind-
ings were blocked with 10 % bovine serum albumin (BSA,
Carl Roth GmbH + Co. KG, solved in 1× TBS-T) for 60 min
Cells were incubated for 60 min with the following primary
antibodies dissolved in 1 % BSA in 1× TBS-T: islet-1 (anti-
rabbit, polyclonal, 1:500, Biozol Diagnostika Vertrieb
GmbH, Eching, Germany), phospho-tau (p-tau, anti-rabbit,
polyclonal, 1:1,000, Biozol Diagnostika Vertrieb GmbH),
microtubule-associated protein 2ab (MAP2ab, anti-mouse,
monoclonal, 1:500, Acris Antibodies GmbH, Hiddenhausen,
Germany), acetylcholine transferase (AChT, anti-rabbit, poly-
clonal, 1:500, Chemicon®, Millipore™), alpha-tubulin (anti-
mouse,monoclonal,1:1,000,Sigma-Aldrich),neurofilamentL
(anti-rabbit, polyclonal, 1:500, Millipore™). The primary an-
tibody was removed by washing the coverslips three times
with 1× TBS-T. Secondary antibodies (dissolved in 1 % BSA
in 1× TBS-T) were added for 45 min in the dark: Alexa Fluor
488goatanti-rabbitand anti-mouseIgG,AlexaFluor568anti-
rabbit and anti-mouse IgG (1:1,000, Molecular Probes®, invi-
trogen™). Nuclei were stained with Hoechst 33258 (1:5,000,
Sigma-Aldrich).
After washing the coverslips three times with 1× TBS-T,
they were embedded in fluorescent mounting medium (Dako
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dark. Immunofluorescencewas visualizedwitha fluorescence
microscope (Axio Imager Z1, AxioCam MRm, Carl Zeiss
MicroImaging GmbH, Jena, Germany). All images were
obtained using identical camera, microscope, and imaging
criteria such as gain, brightness and contrast, and exposure
time. Morphological assessment of axonal swellings was per-
formedinthreeindependentexperiments,foreachgenotypeat
least 145 cells were analyzed. The results are given as mean
and standard deviation. For outgrowth analysis, axons of
motor neurons were identified via positive anti-phospho-tau
staining, dendrites via positive anti-MAP2ab staining. The
followingoutgrowthparametersweremeasuredwiththe Neu-
rolucida 8 software (MBF Bioscience, Williston, USA), and
are given as mean and standard deviation: longest axonal
branch, total axon length (including all branches), longest
dendrite, total dendrite length (of one cell), number of axonal
branches, number of dendrites, and cell body area. An exam-
ple for the outgrowth analysis is shown in Online Resource 1.
In sensory neurons, anti-phospho-tau positive neurite length
(total neurite length, longest neurite) was measured. Results
fromthree independentexperiments werepooled, insummary
atleast183cellsofeachgenotypewereanalyzedforstatistical
differences by ANOVA followed by Bonferroni correction
(SPSS 17.0, SPSS Inc.).
Number and morphology of mitochondria
Mitochondria were stained with Mito Tracker Red (CM-
H2XRos, 25 mM, Molecular Probes®, invitrogen™)a n d
Mito Tracker Green FM (50 mM, Molecular Probes®, invi-
trogen™) in living motor neurons after 4 days in culture for
10 min After replacement of the medium, mitochondria
were visualized with a fluorescence microscope (Axio
Observer Z1, AxioCam MRm, Carl Zeiss MicroImaging
GmbH) with incubation chamber for stable atmosphere
(37°C, 5 % CO2). First, the number of mitochondria in a
10-μm distance of the proximal and distal axon was
counted, and results pooled from four independent experi-
ments. Altogether, at least 53 mitochondria in 18 different
cells were counted for each genotype. Second, the length of
mitochondria from seven independent experiments (at least
109 mitochondria for each genotype) was measured with
Neurolucida 8 software (MBF Bioscience). The results are
indicated as mean and standard deviation (SD). Statistical
analysis by ANOVA and Bonferroni correction was carried
out via SPSS 17.0 (SPSS Inc.).
Time-lapse imaging
Mitochondria were stained and visualized as described above.
Time-lapse images were acquired at a frequency of 1/15 Hz
and exposure time of 355 ms. For statistical analysis of
mitochondrial movements ten independent experiments were
performed. For each genotype, more than 25 mitochondria
w e r et r a c k e db o t hi na n t e r o g r a d ea n dr e t r o g r a d ed i r e c t i o n ,a n d
maximum velocity and average velocity of moving mitochon-
dria were measured with freeware ImageJ software and the
MTrackJ plug-in (http://rsbweb.nih.gov/ij/index.html). Statisti-
caldifference ofmean and standarddeviation wascalculatedby
ANOVA and Bonferroni correction (SPSS 17.0, SPSS Inc.).
Results
Histological analysis of motor cortex, spinal cord,
and muscle in KIF5A
–/– mice
Mice lacking KIF5A have a severe phenotype with death
shortly after birth [29]. We analyzed cortex, spinal cord, and
muscle paraffin sections of KIF5A
–/– embryos (E 18.5) and
confirmed normal morphology of cortex sections. Addition-
ally, muscle tissue appeared normal in all three genotypes
(exemplaryimagesareshowninOnlineResource2).Previous
qualitative histological analysis of brain and spinal cord in
KIF5A
–/– embryos suggested swelling of lower motor neuron
cellbodiesandnuclei,butquantitativedataweremissing[29].
In contrast to these data we found that the nuclear area was
significantly smaller in KIF5A
–/– lower motor neurons of the
spinal cord in comparison to KIF5A
+/+ controls (115±22 vs.
141±27 μm
2). Quantitative analysis of cell body area did not
revealsignificantdifferencesbetweenthegenotypes,although
there was a trend towards smaller cell bodies (241±73 vs.
276±82 μm
2)i nKIF5A
–/– motor neurons.
Reduced survival of KIF5A
–/– motor neurons
Motor and sensory neuron cell cultures were obtained from
the lumbar spinal cord and the adjacent DRGs, dissected from
day E 12.5 mouse embryos. The cells were grown on cover-
slips over 4 days in presence of neurotrophic factors. Cells
were identified as motor and sensory neurons by morphology
and positive anti-islet, anti-AChT, anti-MAP2ab, and anti-
phospho-tau staining. Typical examples are shown in Online
Resource3.KIF5A
–/–motorneuronsshowedreducedsurvival
rates in comparison to heterozygous and wildtype littermates.
After 4 days in vitro (DIV), mean survival of KIF5A
–/– motor
neurons haddeclinedto43%,whereasinKIF5A
+/– 77%,and
in KIF5A
+/+ mice 84 % of the cells survived (Fig. 1,c o n t i n -
uous lines). In sensory neurons, there was no significant
difference between the three genotypes (Fig. 1,b r o k e nl i n e s ) .
Reduced outgrowth of KIF5A
–/– motor and sensory neurons
Fluorescence microscopy of KIF5A
–/– motor neurons
stained with antibodies against phospho-tau and MAP2ab
172 Neurogenetics (2012) 13:169–179revealed no gross morphological abnormalities (data not
shown). Local accumulations of the cytoskeletal protein
neurofilament L in axonal swellings showed a trend towards
being more frequent in of KIF5A
–/– motor neurons (12.4±
5.1 % of cells), in comparison to KIF5A
+/– (9.3±1.0 % of
cells), and KIF5A
+/+ (4.3±4.0 % of cells) motor neurons,
but the difference did not reach statistical significance
(Fig. 2). In sensory neurons, no gross morphological abnor-
malities were observed (data not shown).
Since in HSP, the motor neurons with the longest axons
are preferentially affected, we assessed the influence of
KIF5A knockout on process outgrowth. Motor neurons were
fixed after 2 and 4 days in culture respectively, and axons
were stained with an anti-phospho-tau antibody. Dendrites
were stained by an anti-MAP2ab antibody. After 2 days in
vitro, there was no significant difference neither in axonal
nor in dendritic outgrowth. At that time mean axonal length
was approximately 100 μm, total dendrite length about
35 μm (Fig. 3). After 4 days in culture, axonal and dendritic
outgrowth was impaired in KIF5A
–/– motor neurons. Total
axon length (including all branches) in motor neurons was
significantly reduced in KIF5A
–/– vs. KIF5A
+/–,a n d
KIF5A
+/+ motor neurons (Fig. 4a). Similar results were
obtained for the longest axonal branch (data not shown).
As in axons, the total dendrite length (per cell) was signif-
icantly lower in KIF5A
–/– motor neurons vs. heterozygous
and wildtype neurons (Fig. 4b). Also, the longest dendrite
was reduced in KIF5A
–/– motor neurons in comparison to
controls (data not shown). There was a significant reduction
in the number of axonal branches in KIF5A
–/– vs. KIF5A
+/–
and KIF5A
+/+ motor neurons (Fig. 4c), whereas the number
of dendrites was not altered (Fig. 4d). Cell body area was
significantly reduced in KIF5A
–/– motor neurons (Fig. 4e).
Sensory neurons were fixed after 24 h in culture as
neurites in sensory neurons develop more rapidly than in
Fig. 1 Survival of primary motor and sensory neurons from KIF5A
+/+,
KIF5A
+/–, and KIF5A
–/– mice. The number of initially counted cells
was set 100 % (day 0). The percentage of surviving cells was calcu-
lated for every day in culture. Motor neurons are indicated in continuous
lines,sensory neurons inbrokenlines. Squares show KIF5A
+/+, triangles
KIF5A
+/–, and circles KIF5A
–/– mice. After 4 days in culture mean
survival of KIF5A
–/– motor neurons had declined to 43±6 %, whereas
in KIF5A
+/– 76±5 %, and in KIF5A
+/+ mice 84±6 % of the cells
survived. In sensory neurons, there was nosignificant difference between
the three genotypes at any time point. In total, at least 11 mice were
analyzed per genotype. Mean and SEM are given. * denotes significant
difference with p<0.05betweenKIF5A
+/+ and KIF5A
–/– motor neurons,
** significant difference with p<0.05 between KIF5A
+/+ and KIF5A
–/–,
and KIF5A
+/– and KIF5A
–/– motor neurons
Fig. 2 Morphology of KIF5A
+/+ and KIF5A
–/– motor neurons. Motor
neurons were stained with an antibody against neurofilament L (white). a
Shows examples with axonal swellings (arrows, magnification box), b
without axonal swellings. Bar 20 μm. Bar in the magnification box 10 μm
Fig. 3 Axon and dendrite outgrowth of KIF5A
+/+, KIF5A
+/–,a n d
KIF5A
–/– motor neurons. Total axon length including all branches
(continuous lines) and total dendrite length (broken lines) were measured
after 2 and 4 days in vitro. Squares show KIF5A
+/+, triangles KIF5A
+/–,
and circles KIF5A
–/– motor neurons. Results are given as mean; due to
clarity standard deviation indicators have been omitted. Measured values
were linearly interpolated. For each genotype more than 150 cells from
three independent experiments were analyzed
Neurogenetics (2012) 13:169–179 173motor neurons. In sensory neurons, the total neurite length
was significantly diminished in KIF5A
–/– cells (Fig. 4f).
Similarly, the longest neurite was significantly shortened
in KIF5A
–/– sensory neurons compared to controls (data
not shown). The number of neurites was not altered between
the genotypes (Fig. 4g). In KIF5A
–/– sensory neurons cell
bodies were smaller than in KIF5A
+/+ and KIF5A
+/– sensory
neurons. Surprisingly, cell bodies of KIF5A
+/– sensory neu-
rons were larger than in wildtype (Fig. 4h).
Axonal transport in motor neurons
As axonal transport disturbances of mitochondria may lead to
areducednumberoforganellesinalength-dependentmanner,
we counted mitochondria in proximal and distal parts of the
axon. The overall number of mitochondria in a 10 μms e g -
ment of the proximal and distal end of an axon did not differ
between the genotypes and ranged about seven to ten mito-
chondriainthe proximalpartand six toseven mitochondriain
Fig. 4 Process outgrowth of
motor and sensory neurons
from KIF5A
+/+, KIF5A
+/–, and
KIF5A
–/– mice. For each
genotype more than 150 cells
from three independent
experiments were analyzed.
Results are given as mean and
standard deviation. Total axon
length including all branches
(a), total dendrite length (b),
number of axonal branches (c),
number of dendrites (d), and cell
body area (e) are given for
KIF5A
+/+, KIF5A
+/–,a n d
KIF5A
–/– motorneurons.Neurite
outgrowth (f), number of
neurites (g), and cell body area
(h)i nKIF5A
+/+, KIF5A
+/–,
and KIF5A
–/– sensory neurons.
*p<0.05, ***p<0.001
174 Neurogenetics (2012) 13:169–179the distal part. Detailed results are shown in Table 1.S i n c e
damaged mitochondria often are fragmented and present with a
more round appearance whereas viable mitochondria show an
elongated shape [32, 33] we assessed mitochondrial morphol-
ogy as a potential indicator of impaired mitochondrial function.
In axons of motor neurons the mean length of mitochondria did
not significantly differ between KIF5A
–/– (1.3±0.7 μm),
KIF5A
+/– (1.2±0.7 μm) and KIF5A
+/+ mice (1.4±0.8 μm).
To assess mitochondrial transport as a critical factor of energy
supply especially in distal parts of the axon and at the synapse,
we analyzed mitochondrial movements in axons of motor neu-
rons both in anterograde and retrograde direction using time-
lapse imaging. Tracking of mitochondrial movements over
30 minutes revealed a transport deficit in KIF5A
–/– motor neu-
rons. The maximum velocity and the average velocity of (mov-
ing) mitochondria in anterograde direction were significantly
impaired in KIF5A
–/–compared to KIF5A
+/+ motor neurons.
KIF5A
+/– showed an intermediate velocity of mitochondria in
motor neurons (Fig. 5a,b). The absence of KIF5A led also to a
reduction in retrograde transport velocity, with the maximum
velocity of retrogradely transported mitochondria being signifi-
cantly reduced in comparison to KIF5A
+/+ cells. Similarly, the
average velocity decreased in KIF5A
–/– c e l l si nc o m p a r i s o nt o
KIF5A
+/+ cells (Fig. 5c,d, see also Online Resources 4, 5,a n d6
for movies of mitochondrial movements in motor neurons).
Discussion
Dysfunctional KIF5A causes spastic paraplegia (SPG10)
with predominant motor neuron affection in humans. To
improve the understanding of the underlying pathophysiol-
ogy, we characterized the effect of loss of KIF5A on sur-
vival, morphology, and axonal transport in motor neurons in a
KIF5A
–/– mouse model. In summary, we observed impaired
axonal transport, reduced axonal outgrowth, and reduced sur-
vival of primary motor neurons lacking KIF5A.
KIF5A knockout leads to an axonopathy,
rather than a neuronopathy
Although these observations fit to a primary axonal affec-
tion the possibility that early axonal changes are just an
expression of general dysfunction of motor neurons in
KIF5A
–/– mice cannot be completely ruled out. However,
several observations argue for axonopathy as the primary
problem caused by the lack of KIF5A.
(a) Axon and dendrite growth is not generally impaired but
becomes obvious only when processes exceed a critical
length. After 2 days in culture processes have a similar
length in all genotypes. Especially axons and (to a
lesser extent) dendrites in KIF5A
+/+ and KIF5A
+/–
motor neurons elongate considerably within the next
two days, whereas process length barely increases in
KIF5A
–/– motor neurons (Fig. 3).
(b) The observation of reduced survival of KIF5A
–/– motor
neurons in culture would fit to both a primary axonal
defect and general motor neuron dysfunction. However,
the observation of a normal motor cortex and at most
minorchangesinspinalmotor neuronsinlateembryonic
KIF5A
–/– mice despite a perinatally lethal dysfunction of
motor neurons (probably due to impaired innervation
of respiratory muscles) are in agreement with an
axonopathy.
(c) Furthermore, the observation of an increased number
of axonal swellings in cultured motor neurons lacking
KIF5A points to primary axonal impairment and is in
line with autopsy findings of spastic paraplegia, e.g., in
SPG4, the most frequent form of autosomal dominant
HSP in which impaired microtubule severing is
thought to cause primary axonal disturbance [34]. For
SPG10, no pathoanatomical studies are available.
(d) Defects of anterograde and retrograde transport as ob-
served in our study but also in squid and drosophila
models lacking kinesin-1 are in line with primary
axonopathy. Anterograde transport deficit is likely to
explain limitations in axonal outgrowth whereas the
additional deficit of retrograde transport on the long
run may cause impaired growth factor supply to the
neuron that may contribute to reduced survival of
KIF5A
–/– motor neurons.
KIF5A/KHC disruption impairs axonal transport both
in anterograde and retrograde direction
To assess axonal transport as a potentially critical factor in
the extreme anatomy of motor neurons we tracked mito-
chondrial movements in motor neurons with time-lapse
microscopy. Interestingly, we found a significant reduction
of transport velocity in both directions, anterograde and
retrograde.
Perturbance of anterograde transport seems to be plausi-
ble for a motor protein involved in fast anterograde trans-
port, whereas disturbance of retrograde transport is
surprising at first glance. In accordance with our findings,
Table 1 Number of mitochondria ina 10 μmsegmentoftheproximaland
d i s t a le n do fa na x o ni nKIF5A
+/+, KIF5A
+/–,a n dKIF5A
–/– motor neurons
Number of mitochondria KIF5A
+/+ KIF5A
+/– KIF5A
–/–
Proximal axon (10 μm) 10.2±4.7 7.9±4.6 7.4±2.8
Distal axon (10 μm) 6.0±2.4 6.6±2.3 6.0±3.8
Mean and standard deviation are given. Mitochondria were counted in
at least 18 different cells for each genotype
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transport has been shown in three additional models: Perfu-
sion of squid axoplasms with an antibody against KHC
inhibited rate and number of anterogradely and retrogradely
moving organelles [35, 36]. Drosophila flies lacking the
KIF5A homologue KHC also have an axonal transport
deficit for mitochondria both in the anterograde and retro-
grade direction [37, 38]. In the KIF5A KO mouse model,
neurofilament transport frequency and velocity is reduced in
both directions [30]. The human N256S mutation of the
KIF5A gene in a mouse model causes a reduced frequency
of neurofilament transport in both directions, whereas trans-
port velocity is increased in retrograde and normal in ante-
rograde direction [31].
Anterograde and retrograde transport are interdependent
Different scenarios could explain the axonal transport im-
pairment in both directions. First, if mitochondria are pro-
duced in or near the cell body, they have to be transported
properly to the periphery before they can head back to the
cell body. This fact alone seems not sufficient to explain our
results since the number of mitochondria in the periphery is
not altered. Second, the retrograde motor protein dynein is
synthesized in the cell body and needs to be transported to
distal parts of the axon before participating in retrograde
transport. This hypothesis is supported by the dependence of
anterograde dynein transport on kinesin-1 [36, 39]. Third,
KIF5A could act as a biochemical or biophysical activator
of dynein in axons. In the recent years, the concept of
cargoes concomitantly bound to motors for both directions
has been accepted [40]. The exact mode of motor coordina-
tion and regulation of axonal transport direction and veloc-
ity is still unresolved. Experimental data examining whether
the number of active motors influences transport velocity
and length are controversial [41–43]. In vitro data suggested
a role of the neck/linker region of KIF5A proteins for
transport velocity regulation [44], but this hypothesis was
not supported by in vitro experiments utilizing a human
SPG10 mutation in the neck domain of the KIF5A protein
[28]. The number of other factors implicated in kinesin
activity and transport dynamics is increasing steadily and
depends on the cargo [45]. The interdependence of KIF5A
and dynein is also enforced by the fact that disruption of
dynein function by using RNA interference inhibited neuro-
filamenttransportbothinanterogradeandretrogradedirection
[30]. Mitochondrial transport seems to be influenced amongst
otherfactorsbymitochondrialmembranepotential[46],nerve
growth factor [47], dynamin-related protein-1 [48], and phos-
phatidylinositol [49]. But a global plan of the interactions has
not yet emerged. The concept of “communicating motors”
would be able to explain the observed results in squid axo-
plasm, Drosophila KHC KO and KIF5A KO mouse model.
Beyond mitochondria for power supply and neurofila-
ments as part of the cytoskeleton, the members of the
kinesin-1-family transport a variety of other cargoes, also
including tubulin [24], synaptic vesicles [22, 23], and lyso-
somes [21]. These cargoes could also be critical for neuronal
survival, outgrowth, and synaptic function. However, a de-
tailed understanding of the full repertoire of cargoes trans-
ported by KIF5A is not yet available and requires further
work.
Fig. 5 Axonal transport of
mitochondria in motor neurons.
Maximum and average velocity
of mitochondrial transport in
anterograde (a and b) and
retrograde (c and d) direction in
KIF5A
+/+, KIF5A
+/–, and
KIF5A
–/– motor neurons. Mean
and standard deviation are
given. *p<0.02, ***denotes
p<0.001. Results from ten
independent experiments were
summarized
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than sensory neurons
The outgrowth of processes is impaired in motor neurons of
KIF5A
–/– mice but affects axons more severely than den-
drites. In addition, axon length has to exceed a critical length
until the outgrowth defect gets obvious. This nicely parallels
the situation in patients with SPG10 where the longest axons
of the corticospinal tract innervating the legs are mostly
affected, whereas the shorter axons to the arms are mainly
spared. If the length of processes is critical, the involvement
of other cell types with long processes has to be expected as
well. Indeed, in sensory neurons which have axons of sim-
ilar length as motor neurons we found reduced outgrowth as
well, even though to a lesser extent than in motor neurons.
T h i sw o u l da l s ob ec o n c o r d a n tt ot h eh u m a nd i s e a s e :
patients with SPG10 may have additional sensory deficits,
but much less severe than motor affection. The cause of
primary involvement of motor neurons is not known but
may be due to special functions executed by specific linking
or binding proteins, higher need of common cell functions,
e.g., increased metabolic demand, and/or a lower reserve
capacity. However, a high variability in the age at onset and
disease severity even within one family has been reported
for the HSPs, including SPG10, so additional factors seem
to influence the development of the disease.
Pathogenesis of SPG10
Whether KIF5A mutations cause SPG10 by a lack of func-
tional kinesin (haploinsuffiency) or by a dominant negative
effect is not quite clear. The majority of mutations in SPG10
patients are missense mutations in the motor domain of
kinesin which is responsible for binding of kinesin to micro-
tubules and its movement along microtubules. Indeed, func-
tional in silico analyses found that kinesin with different
missense mutations causing SPG10 in humans leads to a
reduced binding to microtubules or reduced transport veloc-
ity, respectively [28]. The observation that KIF5A
+/– mice
with reduced amounts of KIF5A protein developed normal-
ly also argues against haploinsufficiency as the major mu-
tational effect, but favors a dominant negative effect.
Additionally, we found a severe deficit in survival, out-
growth, and mitochondrial transport in KIF5A
–/– motor neu-
rons, whereas KIF5A
+/– motor neurons did not considerably
differ from wildtype cells, so half the normal amount of
KIF5A seems to be sufficient to maintain neuronal func-
tions. In vivo, the kinesin-1 complex is a heterotetramer
made up of two kinesin heavy chains and two light chains.
In the SPG10 situation, dimers could include two functional
wildtype KIF5A proteins, one wildtype and one mutated
KIF5A or two mutated non-functional KIF5A proteins. In
case of a dominant negative effect the motor neuron would
be left with only 25 % of normal kinesin. Whether this
drastic decrease of functional kinesin is causing disease or,
alternatively, microtubules become blocked from dysfunc-
tional kinesin causing a traffic jam or, as a third scenario,
abnormal kinesin binds to cargo and blocks its processing,
remains to be established.
Our animal model hints at an involvement of mitochon-
drial transport in the pathogenesis of some forms of HSPs.
This might be a link to other HSP forms that are caused by
mitochondrial dysfunction, e.g., SPG7 and SPG13 with
mutations in a mitochondrial protease and chaperone,
respectively.
In summary, our results point out a role of KIF5A in
process outgrowth and axonal transport of mitochondria,
affecting motor neurons more severely than sensory neu-
rons. This gives pathophysiological insights into KIF5A
associated HSP, and matches the clinical findings of pre-
dominant degeneration of the longest axons of the cortico-
spinal tract.
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